IMRT treatment of anal cancer with a scrotal shield
详细信息 查看全文
- 作者：Rodney C. Hood ; C.M.D. ; Rodney.Hood@duke.edu ; Q. Jackie Wu ; Ph.D. ; Ryan McMahon ; Ph.D. ; Brian Czito ; M.D. ; Christopher Willett ; M.D.
- 关键词：Scrotal shields ; IMRT ; Anal cancer
- 刊名：Medical Dosimetry
- 出版年：2012
- 出版时间：Winter, 2012
- 年：2012
- 卷：37
- 期：4
- 页码：432-435
- 全文大小：1604 K
文摘
The risk of sterility in males undergoing radiotherapy in the pelvic region indicates the use of a shielding device, which offers protection to the testes for patients wishing to maintain fertility. The use of such devices in the realm of intensity-modulated radiotherapy (IMRT) in the pelvic region can pose many obstacles during simulation, treatment planning, and delivery of radiotherapy. This work focuses on the development and execution of an IMRT plan for the treatment of anal cancer using a scrotal shielding device on a clinical patient. An IMRT plan was developed using Eclipse treatment planning system (Varian Medical Systems, Palo Alto, CA), using a wide array of gantry angles as well as fixed jaw and fluence editing techniques. When possible, the entire target volume was encompassed by the treatment field. When the beam was incident on the scrotal shield, the jaw was fixed to avoid the device and the collimator rotation optimized to irradiate as much of the target as possible. This technique maximizes genital sparing and allows minimal irradiation of the gonads. When this fixed-jaw technique was found to compromise adequate coverage of the target, manual fluence editing techniques were used to avoid the shielding device. Special procedures for simulation, imaging, and treatment verification were also developed. In vivo dosimetry was used to verify and ensure acceptable dose to the gonads. The combination of these techniques resulted in a highly conformal plan that spares organs and risk and avoids the genitals as well as entrance of primary radiation onto the shielding device.